Neurogene's total assets for Q3 2025 were $287.83M, a decrease of ― from the previous quarter. NGNE total liabilities were $22.29M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.